{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T07:17:12Z","timestamp":1772954232027,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011875","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia, Inova\u00e7\u00f5es e Comunica\u00e7\u00f5es","doi-asserted-by":"publisher","award":["308452\/2021-6"],"award-info":[{"award-number":["308452\/2021-6"]}],"id":[{"id":"10.13039\/501100011875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2022\/13216-0"],"award-info":[{"award-number":["2022\/13216-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.rpth.2025.103017","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T17:19:40Z","timestamp":1755623980000},"page":"103017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Challenges in evaluating thromboembolic risk in acute leukemia: clinical profiling and limitations of current scoring systems"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6510-3101","authenticated-orcid":false,"given":"Luisa V.","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Vanildo R.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael B.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda R.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira D.R.P.","family":"Velloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo M.","family":"Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7908-9073","authenticated-orcid":false,"given":"Fernanda A.","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-3181","authenticated-orcid":false,"given":"Wellington F.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.103017_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/cam4.332","article-title":"A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center","volume":"4","author":"Vu","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.rpth.2025.103017_bib2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.thromres.2014.11.026","article-title":"Thrombotic events in acute promyelocytic leukemia","volume":"135","author":"Mitrovic","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103017_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00277-021-04687-6","article-title":"Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting","volume":"101","author":"Mendes","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rpth.2025.103017_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11864-023-01089-w","article-title":"Thrombosis in acute myeloid leukemia: pathogenesis, risk factors and therapeutic challenges","volume":"24","author":"Olivi","year":"2023","journal-title":"Curr Treat Options in Oncol"},{"key":"10.1016\/j.rpth.2025.103017_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12557","article-title":"Thrombotic potential during pediatric acute lymphoblastic leukemia induction: role of cell-free DNA","volume":"5","author":"Kumar","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103017_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/leu.2012.290","article-title":"The coagulopathy and thrombotic risk associated with L- asparaginase treatment in adults with acute lymphoblastic leukaemia","volume":"27","author":"Truelove","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.rpth.2025.103017_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2004.07.016","article-title":"Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis","volume":"115","author":"Ziegler","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103017_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00277-022-04770-6","article-title":"Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study","volume":"101","author":"Martella","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rpth.2025.103017_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12959-023-00506-2","article-title":"Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients","volume":"21","author":"Owattanapanich","year":"2023","journal-title":"Thromb J"},{"key":"10.1016\/j.rpth.2025.103017_bib10","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1182\/bloodadvances.2022007699","article-title":"D-dimer and risk for thrombosis in adults with newly diagnosed acute lymphoblastic leukemia","volume":"6","author":"Anderson","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2025.103017_bib11","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.3390\/cancers15133477","article-title":"The coagulopathy of acute promyelocytic leukemia: an updated review of pathophysiology, risk stratification, and clinical management","volume":"15","author":"Hermsen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.rpth.2025.103017_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2019.102351","article-title":"Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone","volume":"79","author":"Hou","year":"2019","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.rpth.2025.103017_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.thromres.2021.12.020","article-title":"Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia","volume":"210","author":"Xiao","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103017_bib14","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103017_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12959-019-0202-z","article-title":"Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience","volume":"17","author":"Mirza","year":"2019","journal-title":"Thromb J"},{"key":"10.1016\/j.rpth.2025.103017_bib16","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2016-02-701094","article-title":"Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia","volume":"128","author":"Libourel","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103017_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MPH.0000000000001280","article-title":"Risk markers for significant bleeding and thrombosis in pediatric acute promyelocytic leukemia; report from the Children\u2019s Oncology Group Study AAML0631","volume":"41","author":"Rajpurkar","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.rpth.2025.103017_bib18","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ajh.24130","article-title":"Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: the GRAALL experience","volume":"90","author":"Couturier","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2025.103017_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10428194.2020.1827252","article-title":"A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings?","volume":"62","author":"Silveira","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.rpth.2025.103017_bib20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/16078454.2022.2052602","article-title":"Adult acute lymphoblastic leukemia in a resource-constrained setting: outcomes after expansion of genetic evaluation","volume":"27","author":"Silva","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.rpth.2025.103017_bib21","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1016\/j.clml.2018.11.004","article-title":"Real-life outcomes on acute promyelocytic leukemia in Brazil\u2014early deaths are still a problem","volume":"19","author":"Silva","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.rpth.2025.103017_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/asheducation-2014.1.306","article-title":"Central venous catheter-related thrombosis","volume":"2014","author":"Geerts","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2025.103017_bib24","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2352-3026(17)30014-5","article-title":"Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial","volume":"4","author":"Beyer-Westendorf","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2025.103017_bib25","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"aylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103017_bib26","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","article-title":"A test of missing completely at random for multivariate data with missing values","volume":"83","author":"Little","year":"1988","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.rpth.2025.103017_bib27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00277-023-05158-w","article-title":"The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival","volume":"102","author":"Hellou","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.rpth.2025.103017_bib28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.14744\/nci.2023.92332","article-title":"Incidence of and risk factors for venous thrombosis in hospitalized patients with hematologic malignancies: a single-center, prospective cohort study","volume":"11","author":"Aslan","year":"2024","journal-title":"North Clin Istanb"},{"key":"10.1016\/j.rpth.2025.103017_bib29","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jtha.2024.03.020","article-title":"Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia","volume":"22","author":"Hisada","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103017_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-0039-3400303","article-title":"Development of a clinical prediction rule for venous thromboembolism in patients with acute leukemia","volume":"120","author":"Al-Ani","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103017_bib31","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1182\/blood-2008-08-175745","article-title":"Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival","volume":"113","author":"Ku","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103017_bib32","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.jtha.2025.03.019","article-title":"The incidence and risk of venous thromboembolism in patients with active malignancy and isolated superficial venous thrombosis: a systematic review and meta-analysis (the IROVAM\u2013iSVT review)","volume":"23","author":"Bailey","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103017_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018996","article-title":"A STROBE cohort study of 755 deep and superficial upper-extremity vein thrombosis","volume":"99","author":"Ploton","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rpth.2025.103017_bib34","first-page":"328","article-title":"Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study","volume":"136","author":"Orvain","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103017_bib35","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1016\/j.clml.2020.04.001","article-title":"Toxicity profile of PEG-asparaginase in adult patients with acute lymphoblastic leukemia in brazil: a multicenter cross-sectional study","volume":"20","author":"Silva","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.rpth.2025.103017_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2018.02.150","article-title":"Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia","volume":"165","author":"Prasca","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103017_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41408-024-01178-5","article-title":"Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen","volume":"14","author":"Shimony","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.rpth.2025.103017_bib38","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.3390\/cancers14225640","article-title":"Predictors of early thrombotic events in adult patients with acute myeloid leukemia: a real-world experience","volume":"14","author":"Paterno","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925003413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925003413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:07:43Z","timestamp":1772914063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925003413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2475037925003413"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103017","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in evaluating thromboembolic risk in acute leukemia: clinical profiling and limitations of current scoring systems","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103017"}}